Many prostate cancer (PCa) recurrences are thought to be due to reactivation of disseminated tumor cells (DTCs). We previously found a role of the TAM family of receptor tyrosine kinases TYRO3, AXL, and MERTK in PCa dormancy regulation. However, the mechanism and contributions of the individual TAM receptors is largely unknown. Knockdown of MERTK, but not AXL or TYRO3 by shRNA in PCa cells induced a decreased ratio of Pâ Erk1/2 to Pâ p38, increased expression of p27, NR2F1, SOX2, and NANOG, induced higher levels of histone H3K9me3 and H3K27me3, and induced a G1/G0 arrest, all of which are associated with dormancy. Similar effects were also observed with siRNA. Most importantly, knockdown of MERTK in PCa cells increased metastasis free sur...
Disseminated tumor cells (DTCs) are believed to lie dormant in the marrow before they can be activat...
AbstractOur recent studies have shown that annexin II, expressed on the cell surface of osteoblasts,...
The majority of current treatments used for treatment of prostate cancer (PCa) and leukemia are ofte...
AbstractThe mechanisms that regulate hematopoietic stem cell (HSC) dormancy and self-renewal are wel...
The presence of clinical metastases in the bone marrow of prostate cancer patients represents lethal...
MerTK, a receptor tyrosine kinase (RTK) of the TYRO3/AXL/MerTK family, is expressed in myeloid linea...
The mechanisms that regulate hematopoietic stem cell (HSC) dormancy and self-renewal are well establ...
Receptor tyrosine kinase Mer (MerTK) has been shown to be highly expressed in Glioblastoma multiform...
<p>Receptor tyrosine kinase Mer (MerTK) has been shown to be highly expressed in Glioblastoma multif...
PI3K (phosphoinositide 3-kinase)/AKT and RAS/MAPK (mitogen-activated protein kinase) pathway coactiv...
MER receptor tyrosine kinase (MERTK) is expressed in a variety of malignancies, including glioblasto...
MER receptor tyrosine kinase (MERTK) is expressed in a variety of malignancies, including glioblasto...
Abstract Background Disseminated tumor cells (DTCs) can enter a dormant state and cause no symptoms ...
Metastatic melanoma is one of the most aggressive forms of cutaneous cancers. Although recent therap...
Simple Summary Prostate cancer is driven by androgen receptor-regulated transcription and is a leadi...
Disseminated tumor cells (DTCs) are believed to lie dormant in the marrow before they can be activat...
AbstractOur recent studies have shown that annexin II, expressed on the cell surface of osteoblasts,...
The majority of current treatments used for treatment of prostate cancer (PCa) and leukemia are ofte...
AbstractThe mechanisms that regulate hematopoietic stem cell (HSC) dormancy and self-renewal are wel...
The presence of clinical metastases in the bone marrow of prostate cancer patients represents lethal...
MerTK, a receptor tyrosine kinase (RTK) of the TYRO3/AXL/MerTK family, is expressed in myeloid linea...
The mechanisms that regulate hematopoietic stem cell (HSC) dormancy and self-renewal are well establ...
Receptor tyrosine kinase Mer (MerTK) has been shown to be highly expressed in Glioblastoma multiform...
<p>Receptor tyrosine kinase Mer (MerTK) has been shown to be highly expressed in Glioblastoma multif...
PI3K (phosphoinositide 3-kinase)/AKT and RAS/MAPK (mitogen-activated protein kinase) pathway coactiv...
MER receptor tyrosine kinase (MERTK) is expressed in a variety of malignancies, including glioblasto...
MER receptor tyrosine kinase (MERTK) is expressed in a variety of malignancies, including glioblasto...
Abstract Background Disseminated tumor cells (DTCs) can enter a dormant state and cause no symptoms ...
Metastatic melanoma is one of the most aggressive forms of cutaneous cancers. Although recent therap...
Simple Summary Prostate cancer is driven by androgen receptor-regulated transcription and is a leadi...
Disseminated tumor cells (DTCs) are believed to lie dormant in the marrow before they can be activat...
AbstractOur recent studies have shown that annexin II, expressed on the cell surface of osteoblasts,...
The majority of current treatments used for treatment of prostate cancer (PCa) and leukemia are ofte...